Cargando…

Administration of bisphosphonate for hypercalcemia associated with oral cancer

BACKGROUND: The efficacy of treating hypercalcemia with bisphosphonate (BP) in patients with advanced oral cancer has not been fully investigated. This retrospective study evaluated the clinical course of hypercalcemic patients with and without BP treatment. METHODS: Sixteen hypercalcemic patients,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Onizawa, Kojiro, Yoshida, Hiroshi
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1459855/ https://www.ncbi.nlm.nih.gov/pubmed/16603094 http://dx.doi.org/10.1186/1746-160X-2-9

Ejemplares similares

Humoral hypercalcemia of pregnancy treated with bisphosphonates
por: Koren, Ronit, et al.
Publicado: (2018)

SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019)

Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia
por: Kilinc, Suna, et al.
Publicado: (2020)

Eliminating the need for fasting with oral administration of bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2013)

Denosumab-Induced Rebound Hypercalcemia Treated With Bisphosphonates in a Pediatric Patient
por: Gandolfi, Anne, et al.
Publicado: (2023)

Denosumab for Patients With Persistent or Relapsed Hypercalcemia of Malignancy Despite Recent Bisphosphonate Treatment
por: Hu, Mimi I., et al.
Publicado: (2013)

MON-335 Bisphosphonate and Denosumab Refractory Hypercalcemia of Malignancy: What Else Is at Play?
por: Patel, Reshma, et al.
Publicado: (2020)

SAT259 A Rare Case Of Bisphosphonate Refractory Hypercalcemia; Cancer Masquerading As Hidradenitis Suppurativa
por: Robles, Lydia A, et al.
Publicado: (2023)

Oral bisphosphonates and colorectal cancer
por: Vogtmann, Emily, et al.
Publicado: (2017)

Single Dose of Denosumab Effective for Management of Bisphosphonate-Refractory Hypercalcemia of Malignancy Related to Non-Small Cell Lung Cancer
por: Dinh, Kathryn, et al.
Publicado: (2021)

Regeneration of Cochlear Synapses by Systemic Administration of a Bisphosphonate
por: Seist, Richard, et al.
Publicado: (2020)

Severe Oral Mucosal Ulceration Associated with Oral Bisphosphonate Use: The Importance of Imparting Proper Instructions on Medication Administration and Intake
por: Chandran, Manju, et al.
Publicado: (2021)

PB2142: SERUM OSTEOCALCIN AS A PREDICTOR FOR THE RISK OF DENOSUMAB AND BISPHOSPHONATE INDUCED HYPOCALCEMIA IN MYELOMA PATIENTS WITH HYPERCALCEMIA
por: Ding, Yuehua, et al.
Publicado: (2023)

Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers
por: Vogtmann, Emily, et al.
Publicado: (2015)

Atrial fibrillation and the use of oral bisphosphonates
por: Pazianas, Michael, et al.
Publicado: (2011)

Radiation-Induced Carotid Artery Stenosis in a Patient with Carcinoma of the Oral Floor
por: Seto, Kahori, et al.
Publicado: (2013)

Animal Models of Cancer-Associated Hypercalcemia
por: Kohart, Nicole A., et al.
Publicado: (2017)

Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
por: Rajput, Swati, et al.
Publicado: (2023)

The association between adherence with oral bisphosphonates and the risk of breast cancer in post-menopausal women
por: Rouach, Vanessa, et al.
Publicado: (2018)

The role of bisphosphonates in breast cancer: Development of bisphosphonates
por: Fleisch, Herbert
Publicado: (2002)

Impact on Bisphosphonate Persistence and Compliance: Daily Postprandial Administration
por: Park, Chan Ho, et al.
Publicado: (2019)

Immunohistochemical Femoral Nerve Study Following Bisphosphonates Administration
por: Karakousis, Vasileios Alexandros, et al.
Publicado: (2020)

Implant failure associated with oral bisphosphonate-related osteonecrosis of the jaw
por: Shin, Eun-Young, et al.
Publicado: (2010)

SUN-508 Intravenous Bisphosphonates Induced Renal Injury with Nephrotic Range Proteinuria in a Patient with Severe Hypercalcemia Secondary to Parathyroid Carcinoma
por: Gorantla, Yamuna, et al.
Publicado: (2019)

Determinants of Oral Bisphosphonate Use Beyond 5 Years
por: Izano, Monika A., et al.
Publicado: (2020)

Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw
por: Kalyan, Shirin, et al.
Publicado: (2015)

Oral bisphosphonate-associated osteonecrosis of maxillary bone: A review of 18 cases
por: López-D’alessandro, Edgardo, et al.
Publicado: (2014)

Novel formulations of oral bisphosphonates in the treatment of osteoporosis
por: Fuggle, Nicholas, et al.
Publicado: (2022)

Transient hypercalcemia in a patient with SAPHO syndrome
por: Yoshida, Tadashi, et al.
Publicado: (2021)

Hypercalcemia associated with a parathyroid cyst.
por: Cooper, K. J., et al.
Publicado: (1994)

Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss
por: Kubota, Takuo, et al.
Publicado: (2006)

ODP081 Bisphosphonates: To Give or Not to Give, that is the Question – A case of prolonged hypercalcemia in a patient with severe rhabdomyolysis complicated by bilateral foot drop
por: Musurakis, Clio, et al.
Publicado: (2022)

Hypercalcemia of Malignancy and Colorectal Cancer
por: Galindo, Rodolfo J., et al.
Publicado: (2016)

Study of serum ctx in 50 oral surgical patients treated with oral bisphosphonates
por: Flichy-Fernández, Antonio J., et al.
Publicado: (2012)

Oral Bisphosphonate and Risk of Esophageal Cancer: A Nationwide Claim Study
por: Seo, Gi Hyeon, et al.
Publicado: (2015)

Oral bisphosphonate use and lung cancer incidence among postmenopausal women
por: Tao, M H, et al.
Publicado: (2018)

Atypical Complete Femoral Fractures Associated with Bisphosphonate Use or Not Associated with Bisphosphonate Use: Is There a Difference?
por: Kim, Sang-Min, et al.
Publicado: (2016)

Comparison of the Effect of Oral Versus Intravenous Bisphosphonate Administration on Osteoclastogenesis in Advanced-Stage Medication-Related Osteonecrosis of the Jaw Patients
por: Kim, Hye-Won, et al.
Publicado: (2021)

Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
por: Höer, Ariane, et al.
Publicado: (2009)

Hypercalcemia of Malignancy
por: Malangone, Steve, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tf473lhkh4jvviitcpsrbt2pn7